![Mitchell Mutz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mitchell Mutz
Director/Board Member at
Pandion Operations, Inc.
Profile
Mitchell W.
Mutz was the founder of Amplyx Pharmaceuticals, Inc., founded in 2006, where the title held was Chief Scientific Officer from 2011 to 2016.
Current jobs include Director at Pandion Operations, Inc., Director at Bonum Therapeutics, Inc., and Senior Principal at Samsara BioCapital LLC starting in 2025.
Former jobs include Chief Financial Officer & Director at EpiBiologics, Inc., Director at BlueLight Therapeutics, Inc., Director at Purigen Biosystems, Inc., Senior Investment Director at Roche Ventures from 2019 to 2020, Independent Director at Pandion Therapeutics, Inc., Entrepreneur Partner at Vivo Capital LLC from 2021 to 2025, Partner at Codon Innovation LLC from 2020 to 2021, Principal Scientist at Labcyte, Inc., Board Member at Good Therapeutics, Inc., Board Member at Jasper Tx Corp., and Venture Partner at Codon Innovation LLC from 2016 to 2017.
Education includes a doctorate from Rochester Christian University conferred in 1997, a graduate degree from Goldsmiths College University of London conferred in 1988, and an undergraduate degree from Oberlin College conferred in 1985.
Mitchell Mutz active positions
| Companies | Position | Start |
|---|---|---|
Pandion Operations, Inc.
 Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for autoimmune, inflammatory and transplant indications | Director/Board Member | - |
Bonum Therapeutics, Inc.
 Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Director/Board Member | - |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Private Equity Investor | 2025-06-30 |
Former positions of Mitchell Mutz
| Companies | Position | End |
|---|---|---|
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle-market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life sciences. It provides financing for early stage, growth stage, buyouts, spin-offs, and restructurings. The firm also acquires controlling interest. | Private Equity Investor | 2025-07-31 |
Codon Capital
 Codon Capital Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 2021-06-30 |
| PANDION THERAPEUTICS, INC. | Director/Board Member | 2020-12-01 |
Roche Ventures
 Roche Ventures Investment ManagersFinance Roche Ventures invests in companies located in Switzerland and the United States. The firm focuses on pharmaceuticals, diagnostics and digital health. It participates in early stage capital transactions with an investment size of CHF 3 - 10 million. It acquires minority stakes and also makes follow-on financing. | Private Equity Investor | 2020-07-31 |
Codon Capital
Codon Capital Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 2016-12-31 |
Training of Mitchell Mutz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle-market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life sciences. It provides financing for early stage, growth stage, buyouts, spin-offs, and restructurings. The firm also acquires controlling interest. | Finance |
BlueLight Therapeutics, Inc.
 BlueLight Therapeutics, Inc. BiotechnologyHealth Technology Develops novel systems to analyze real-time protein function for research and clinical applications | Health Technology |
Purigen Biosystems, Inc.
 Purigen Biosystems, Inc. BiotechnologyHealth Technology Engages in extracting, enriching and quantifying DNA and RNA from biological samples | Health Technology |
Oberlin College
 Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Labcyte, Inc.
 Labcyte, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology tools company that manufactures and markets echo liquid handling systems | Health Services |
Roche Ventures
Roche Ventures Investment ManagersFinance Roche Ventures invests in companies located in Switzerland and the United States. The firm focuses on pharmaceuticals, diagnostics and digital health. It participates in early stage capital transactions with an investment size of CHF 3 - 10 million. It acquires minority stakes and also makes follow-on financing. | Finance |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Health Technology |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Pandion Operations, Inc.
Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for autoimmune, inflammatory and transplant indications | Commercial Services |
Good Therapeutics, Inc.
 Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops bio-therapeutics and self-regulating drugs | Health Technology |
Jasper Tx Corp.
 Jasper Tx Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel therapeutics for autoimmune diseases | Health Technology |
Codon Capital
Codon Capital Investment ManagersFinance Functions as an alternative investment manager | Finance |
Goldsmiths College University of London
 Goldsmiths College University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bonum Therapeutics, Inc.
Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Commercial Services |
EpiBiologics, Inc.
 EpiBiologics, Inc. BiotechnologyHealth Technology Develops antibodies to degrade disease causing proteins | Health Technology |
- Stock Market
- Insiders
- Mitchell Mutz
